![Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies | Nature Reviews Neuroscience Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies | Nature Reviews Neuroscience](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrn3549/MediaObjects/41583_2013_Article_BFnrn3549_Fig1_HTML.jpg)
Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies | Nature Reviews Neuroscience
![Parkinson disease and the immune system — associations, mechanisms and therapeutics | Nature Reviews Neurology Parkinson disease and the immune system — associations, mechanisms and therapeutics | Nature Reviews Neurology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41582-020-0344-4/MediaObjects/41582_2020_344_Fig1_HTML.png)
Parkinson disease and the immune system — associations, mechanisms and therapeutics | Nature Reviews Neurology
![Emerging therapies in Parkinson disease — repurposed drugs and new approaches | Nature Reviews Neurology Emerging therapies in Parkinson disease — repurposed drugs and new approaches | Nature Reviews Neurology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41582-019-0155-7/MediaObjects/41582_2019_155_Fig1_HTML.png)
Emerging therapies in Parkinson disease — repurposed drugs and new approaches | Nature Reviews Neurology
![Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease | Nature Reviews Neuroscience Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease | Nature Reviews Neuroscience](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrn2915/MediaObjects/41583_2010_Article_BFnrn2915_Fig1_HTML.jpg)
Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease | Nature Reviews Neuroscience
![Pathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein | Nature Reviews Neuroscience Pathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein | Nature Reviews Neuroscience](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrn983/MediaObjects/41583_2002_Article_BFnrn983_Fig1_HTML.jpg)
Pathogenesis of parkinson's disease: dopamine, vesicles and α-synuclein | Nature Reviews Neuroscience
![Antioxidants | Free Full-Text | Antioxidant Therapy in Parkinson's Disease: Insights from Drosophila melanogaster Antioxidants | Free Full-Text | Antioxidant Therapy in Parkinson's Disease: Insights from Drosophila melanogaster](https://www.mdpi.com/antioxidants/antioxidants-09-00052/article_deploy/html/images/antioxidants-09-00052-g001.png)
Antioxidants | Free Full-Text | Antioxidant Therapy in Parkinson's Disease: Insights from Drosophila melanogaster
![Synucleinopathy-associated pathogenesis in Parkinson's disease and the potential for brain-derived neurotrophic factor | npj Parkinson's Disease Synucleinopathy-associated pathogenesis in Parkinson's disease and the potential for brain-derived neurotrophic factor | npj Parkinson's Disease](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41531-021-00179-6/MediaObjects/41531_2021_179_Fig1_HTML.png)
Synucleinopathy-associated pathogenesis in Parkinson's disease and the potential for brain-derived neurotrophic factor | npj Parkinson's Disease
![Artificial intelligence-enabled detection and assessment of Parkinson's disease using nocturnal breathing signals | Nature Medicine Artificial intelligence-enabled detection and assessment of Parkinson's disease using nocturnal breathing signals | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-01932-x/MediaObjects/41591_2022_1932_Fig1_HTML.png)